App therapy for Crohn's: stress relief in your pocket

NCT ID NCT06221254

Recruiting now Symptom relief Sponsor: Soroka University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a smartphone app called COBMINDEX that teaches stress-reduction techniques to people with Crohn's disease. Researchers want to see if using the app improves wellbeing, fatigue, and pain as much as working with a human therapist. The trial will enroll 200 adults with Crohn's who are stable on their current treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: COBMINDEX smartphone application (cognitive, behavioral, and mindfulness-based stress reduction)
What this could lead to: If successful, this app could offer a convenient, low-cost way for Crohn's patients to reduce stress and improve quality of life at home.
What could go wrong: This is an early-stage study with 200 participants, and the app may not prove as effective as in-person therapy. Results may not apply to all Crohn's patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN DISEASE

Contacts and locations

Locations

Belinson Medical Center
NOT_YET_RECRUITING

Petah Tikva, 4941492, Israel
Rambam Health Care Campus i
NOT_YET_RECRUITING

Haifa, 3109601, Israel
Sheba Medical Center
NOT_YET_RECRUITING

Ramat Gan, 5266202, Israel
Soroka University Medical Center
RECRUITING

Beersheba, 8410101, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.